However, the role of HuR-β-catenin axis in breast cancer invasion and metastasis needs to be confirmed, and whether HuR inhibition induced CD82 upregulation is related to β-catenin reduction, remains further studies. This evidence concerns the gene CD82 and breast carcinoma.